EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Reappraisal and updated review of maggot debridement therapy in chronic lower extremity ulcers

Gelan Shamloul, Amor Khachemoune iD

International Journal of Dermatology · 2023

DOI: 10.1111/ijd.16619 ↗

At a glance

Übersichtsarbeit in International Journal of Dermatology, 2023. Written by Gelan Shamloul and 1 co-authors. Institution: Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA. Major MEDLINE topics: Diabetic Foot, Diptera, Leg Ulcer. Cited 19 times so far (Crossref); 41 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Dating back to the mid‐1500s, maggot debridement therapy (MDT) has been a viable treatment modality for chronic wounds. In early 2004, the sterile larvae of Lucilia sericata received FDA approval for medical marketing for neuropathic, venous, and pressure ulcers, traumatic or surgical wounds, and nonhealing wounds that have not responded to standard care. However, it currently remains an under‐utilized therapy. The proven efficacy of MDT begs the question if this treatment modality should be considered as a first‐line option for all or a subset of chronic lower extremity ulcers.

Objective

This article aims to address the history, production, and evidence of MDT and discuss future considerations for maggot therapy in the healthcare field.

Methods

A literature search using the PubMed database was conducted using keywords, such as wound debridement, maggot therapy, diabetic ulcers, venous ulcers, among others.

Results

MDT reduced short‐term morbidity in non‐ambulatory patients with neuroischemic diabetic ulcers and comorbidity with peripheral vascular disease. Larval therapy was associated with statistically significant bioburden reductions against both Staphylococcus aureus and Pseudomonas aeruginosa . Faster time to debridement was achieved when chronic venous or mixed venous and arterial ulcers were treated with maggot therapy versus hydrogels.

Conclusions

The literature supports the use of MDT in decreasing the significant costs of treating chronic lower extremity ulcers, with emphasis on those of diabetic origin. Additional studies with global standards for reporting outcomes are necessary to substantiate our results.

Subjects

MeSH terms (MEDLINE)

Diabetic FootDipteraLeg UlcerAnimalsHumansDebridementLarvaLower ExtremityUlcerWound Healing

Authors and institutions

  • Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA.
  • Veterans Affairs Hospital and SUNY Downstate Dermatology Service, Brooklyn, NY, USA.

ORCID profiles: Amor Khachemoune

Cite

APA

Shamloul, G., & Khachemoune, A. (2023). Reappraisal and updated review of maggot debridement therapy in chronic lower extremity ulcers. International Journal of Dermatology. https://doi.org/10.1111/ijd.16619

Vancouver

Shamloul G, Khachemoune A. Reappraisal and updated review of maggot debridement therapy in chronic lower extremity ulcers. International Journal of Dermatology. 2023. doi:10.1111/ijd.16619

BibTeX
@article{Shamloul2023,
  author = {Shamloul, Gelan and Khachemoune, Amor},
  title = {Reappraisal and updated review of maggot debridement therapy in chronic lower extremity ulcers},
  journal = {International Journal of Dermatology},
  year = {2023},
  doi = {10.1111/ijd.16619}
}
Start for free →